Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,058,871
-$4,252,740 QoQ
Shares Held
362,272
-16.8% QoQ
Ownership
0.243%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#59
of 329 holders
Holding Since
Mar 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. PCVX ranks #14 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
659,279 | $123,469,771 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
1,417,916 | $112,426,559 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
889,298 | $109,010,148 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
697,692 | $42,112,689 | |
| 5 | MRNA |
Moderna, Inc.
|
560,819 | $39,274,154 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
276,455 | $31,701,094 | |
| 7 | LBRX |
Lb Pharmaceuticals Inc
|
863,947 | $28,039,399 | |
| 8 | PRAX |
Praxis Precision Medicines, Inc.
|
80,846 | $27,066,432 |
All Filings in PCVX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,058,871 | 362,272 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,311,611 | 435,581 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,293,918 | 244,775 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,816,795 | 244,775 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $7,957,635 | 244,775 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,216,806 | 164,640 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,174,308 | 197,585 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $25,005,818 | 218,831 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $1,570,000 | 25,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,274,500 | 25,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,248,500 | 25,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,686,600 | 45,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,157,750 | 45,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,250,400 | 52,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,133,696 | 52,100 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,258,215 | 52,100 | Shares | Sole | 2022-05-17 | |
| No filing history on record for this holder in this stock. | ||||||